<?xml version="1.0" encoding="ASCII"?>
<!-- XBRL document created with Praxa -->
<!-- Copyright (c) 2026 Praxa LLC. All Rights Reserved.-->
<!-- Creation Date: 2026-09-16T11:15:50.0564+00:00 -->
<xs:schema targetNamespace="http://nlspharma.com/20260630" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ncel="http://nlspharma.com/20260630" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:srt="http://fasb.org/srt/2026" xmlns:dei="http://xbrl.sec.gov/dei/2026">
  <xs:import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd" />
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ncel-20260630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ncel-20260630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ncel-20260630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ncel-20260630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple" />
      <link:roleType roleURI="http://nlspharma.com/20260630/role/Cover" id="Cover">
        <link:definition>995300 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/InterimConsolidatedBalanceSheets" id="InterimConsolidatedBalanceSheets">
        <link:definition>995301 - Statement - Interim Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/InterimConsolidatedBalanceSheetsParentheticals" id="InterimConsolidatedBalanceSheetsParentheticals">
        <link:definition>995302 - Statement - Interim Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/InterimConsolidatedStatementsofProfitorLossandOtherComprehensiveLoss" id="InterimConsolidatedStatementsofProfitorLossandOtherComprehensiveLoss">
        <link:definition>995303 - Statement - Interim Consolidated Statements of Profit or Loss and Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/InterimStatementsofChangesinShareholdersEquity" id="InterimStatementsofChangesinShareholdersEquity">
        <link:definition>995304 - Statement - Interim Statements of Changes in Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/InterimConsolidatedStatementsofCashFlows" id="InterimConsolidatedStatementsofCashFlows">
        <link:definition>995305 - Statement - Interim Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/General" id="General">
        <link:definition>995306 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/UnauditedInterimFinancialStatements" id="UnauditedInterimFinancialStatements">
        <link:definition>995307 - Disclosure - Unaudited Interim Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/PrepaidExpensesandOtherAccountsReceivables" id="PrepaidExpensesandOtherAccountsReceivables">
        <link:definition>995308 - Disclosure - Prepaid Expenses and Other Accounts Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/TradePayables" id="TradePayables">
        <link:definition>995309 - Disclosure - Trade Payables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/AccountsPayable" id="AccountsPayable">
        <link:definition>995310 - Disclosure - Accounts Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/Equity" id="Equity">
        <link:definition>995311 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/LossPerShare" id="LossPerShare">
        <link:definition>995312 - Disclosure - Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>995313 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/UnauditedInterimFinancialStatementsPolicies" id="UnauditedInterimFinancialStatementsPolicies">
        <link:definition>996314 - Disclosure - Unaudited Interim Financial Statements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/PrepaidExpensesandOtherAccountsReceivablesTables" id="PrepaidExpensesandOtherAccountsReceivablesTables">
        <link:definition>996315 - Disclosure - Prepaid Expenses and Other Accounts Receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/TradePayablesTables" id="TradePayablesTables">
        <link:definition>996316 - Disclosure - Trade Payables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/AccountsPayableTables" id="AccountsPayableTables">
        <link:definition>996317 - Disclosure - Accounts Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/LossPerShareTables" id="LossPerShareTables">
        <link:definition>996318 - Disclosure - Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/GeneralDetails" id="GeneralDetails">
        <link:definition>996319 - Disclosure - General (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/PrepaidExpensesandOtherAccountsReceivablesScheduleofPrepaidExpensesandOtherAccountsReceivablesDetails" id="PrepaidExpensesandOtherAccountsReceivablesScheduleofPrepaidExpensesandOtherAccountsReceivablesDetails">
        <link:definition>996320 - Disclosure - Prepaid Expenses and Other Accounts Receivables - Schedule of Prepaid Expenses and Other Accounts Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/TradePayablesScheduleofTradePayablesDetails" id="TradePayablesScheduleofTradePayablesDetails">
        <link:definition>996321 - Disclosure - Trade Payables - Schedule of Trade Payables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/AccountsPayableDetails" id="AccountsPayableDetails">
        <link:definition>996322 - Disclosure - Accounts Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/AccountsPayableScheduleofAccountsPayableDetails" id="AccountsPayableScheduleofAccountsPayableDetails">
        <link:definition>996323 - Disclosure - Accounts Payable - Schedule of Accounts Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/EquityDetails" id="EquityDetails">
        <link:definition>996324 - Disclosure - Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/LossPerShareDetails" id="LossPerShareDetails">
        <link:definition>996325 - Disclosure - Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/LossPerShareScheduleofDilutedNetLossPerShareDetails" id="LossPerShareScheduleofDilutedNetLossPerShareDetails">
        <link:definition>996326 - Disclosure - Loss Per Share - Schedule of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://nlspharma.com/20260630/role/SubsequentEventsDetails" id="SubsequentEventsDetails">
        <link:definition>996327 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ncel_GeneralDetailsTable" name="GeneralDetailsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_EquityLineOfCreditAgreementMember" name="EquityLineOfCreditAgreementMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_RatioOfCommonStockInExchangeForMerger" name="RatioOfCommonStockInExchangeForMerger" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="ncel_SecuritiesPurchaseAgreementsMember" name="SecuritiesPurchaseAgreementsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_BonusLiabilityToRelatedParties" name="BonusLiabilityToRelatedParties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="ncel_EquityTable" name="EquityTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_PrefundedWarrantsMember" name="PrefundedWarrantsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_SubesequentEventsDetailsTable" name="SubesequentEventsDetailsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_ScheduleOfDilutedNetLossPerShareAbstract" name="ScheduleOfDilutedNetLossPerShareAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_LegacyAndPlacementAgentWarrantsMember" name="LegacyAndPlacementAgentWarrantsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_RecapitalizationOfOrdinaryShares" name="RecapitalizationOfOrdinaryShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="ncel_April2026PIPEFinancingMember" name="April2026PIPEFinancingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_PreModification" name="PreModification" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="ncel_PostModificationShares" name="PostModificationShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="ncel_RecapitalizationExchangeRatio" name="RecapitalizationExchangeRatio" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="ncel_PreferredParticipationCertificatesMember" name="PreferredParticipationCertificatesMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_AggregateLiquidationPreference" name="AggregateLiquidationPreference" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="ncel_July2026PIPEOfferingMember" name="July2026PIPEOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_PercentageOfPremiumOnClosingPriceOfCommonShares" name="PercentageOfPremiumOnClosingPriceOfCommonShares" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="ncel_PreMergerNLSPreferredSharesMember" name="PreMergerNLSPreferredSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_FinancingExpensesRelatedToConvertibleInstrument" name="FinancingExpensesRelatedToConvertibleInstrument" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="ncel_StockIssuedDuringPeriodOfValueIssuanceOfCommonSharesAndPreFundedWarrantsInPrivatePlacementOfferingsNet" name="StockIssuedDuringPeriodOfValueIssuanceOfCommonSharesAndPreFundedWarrantsInPrivatePlacementOfferingsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="ncel_StockIssuedDuringPeriodOfSharesIssuanceOfCommonSharesAndPreFundedWarrantsInPrivatePlacementOfferingsNet" name="StockIssuedDuringPeriodOfSharesIssuanceOfCommonSharesAndPreFundedWarrantsInPrivatePlacementOfferingsNet" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="ncel_ReceiptOfLoanFromInterestedParties" name="ReceiptOfLoanFromInterestedParties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="ncel_StockIssuedDuringPeriodOfValueOrdinarySharesIssuedUponConversionOfPreferredSharesAndPPCs" name="StockIssuedDuringPeriodOfValueOrdinarySharesIssuedUponConversionOfPreferredSharesAndPPCs" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="ncel_StockIssuedDuringPeriodOfSharesOrdinarySharesIssuedUponConversionOfPreferredSharesAndPPCs" name="StockIssuedDuringPeriodOfSharesOrdinarySharesIssuedUponConversionOfPreferredSharesAndPPCs" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="ncel_AdjustmentsToAdditionalPaidInCapitalDeemedDividendOnPreferredSharesPPCsAndWarrants" name="AdjustmentsToAdditionalPaidInCapitalDeemedDividendOnPreferredSharesPPCsAndWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="ncel_InProcessResearchandDevelopmentAsset" name="InProcessResearchandDevelopmentAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="ncel_TheoreticalWagesToAnInterestedParty" name="TheoreticalWagesToAnInterestedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="ncel_RecentlyAccountingPronouncementsNotYetAdoptedPolicyTextBlock" name="RecentlyAccountingPronouncementsNotYetAdoptedPolicyTextBlock" type="dtr:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="ncel_SignificantAccountingPoliciesPolicyTextBlock" name="SignificantAccountingPoliciesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="ncel_DeferredChargesAndOtherAssets" name="DeferredChargesAndOtherAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="ncel_AccountPayableOpenAccounts" name="AccountPayableOpenAccounts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="ncel_StockOptionsMember" name="StockOptionsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_ConvertiblePreferredSharesAndPPCsMember" name="ConvertiblePreferredSharesAndPPCsMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_TwoThousandTwentyFiveEquityIncentivePlanMember" name="TwoThousandTwentyFiveEquityIncentivePlanMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="ncel_UnderlyingWarrantShares" name="UnderlyingWarrantShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="ncel_PercentageOfPreferredStockAccruesDividends" name="PercentageOfPreferredStockAccruesDividends" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="ncel_FinancingExpensesRelatedToConvertibleInstruments" name="FinancingExpensesRelatedToConvertibleInstruments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="ncel_NonoperatingFinancingIncome" name="NonoperatingFinancingIncome" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="ncel_DeemedDividend" name="DeemedDividend" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="ncel_AccruedDividend" name="AccruedDividend" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
</xs:schema>
